Market Cap 6.35B
Revenue (ttm) 3.37B
Net Income (ttm) 113.10M
EPS (ttm) N/A
PE Ratio 21.25
Forward PE 22.58
Profit Margin 3.36%
Debt to Equity Ratio 0.82
Volume 1,776,100
Avg Vol 3,407,628
Day's Range N/A - N/A
Shares Out 151.94M
Stochastic %K 66%
Beta 1.26
Analysts Sell
Price Target $47.64

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, inte...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 663 3660
Fax: 978 663 5585
Address:
40 Manning Road, Billerica, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:50 AM
$BRKR: The last close at $41.62 indicates a strong position above the 30-day moving average (MA30) of $38.43 and the 50-day moving average (MA50) of $36.04, suggesting bullish momentum. The RSI at 62.46 indicates that the stock is nearing overbought territory, but not excessively so, allowing for potential further upside. The recent high of $43.37 provides a key resistance level, while the low of $28.53 establishes a solid support base. Directional bias is bullish due to the price being above both MAs and the recent high. Suggested entry is at $41.50, with a stop-loss at $40.00 to manage risk. Target 1 is set at $43.00, just below the 60D high, and Target 2 at $44.00, allowing for potential breakout gains. Monitor RSI for signs of reversal as targets approach. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:23 AM
$BRKR: The last close at $41.79 indicates a strong position above the 30-day MA of $38.28 and the 50-day MA of $35.83, suggesting bullish momentum. The RSI at 61.48 indicates the stock is approaching overbought territory but is not yet there, allowing for potential upward movement. The recent 60-day high of $43.37 provides a clear resistance level, while the low of $28.53 offers significant support. Directional bias is bullish due to the stock trading above key moving averages and the RSI indicating strength. Suggested entry: $41.80 (slightly above the last close to confirm momentum). Stop: $40.00 (below recent support levels). Targets: $43.00 (near the 60D high) and $44.00 (psychological resistance). Monitor for any changes in market sentiment or volatility that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:30 AM
$BRKR: The last close at $41.73 indicates a strong position just below the 60D high of $41.81. The RSI of 61.43 suggests bullish momentum, but it is approaching overbought territory, which may limit upside potential. The MA30 at $37.79 and MA50 at $35.32 indicate a positive trend, supporting a bullish bias. Given the current market context, a suggested entry point could be around $41.50, slightly below the last close to confirm buying interest. A stop loss can be placed at $40.00 to limit potential losses. For targets, consider a first target at $42.50, just above the recent high, and a second target at $43.50, allowing for further upside if momentum continues. Overall, the trade plan is to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
Professler
Professler Nov. 12 at 7:50 PM
$BRKR The buys keep coming in here. Up 40% in 3 months. No reason this shouldn't be 60s soon.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:06 AM
$BRKR: The last close at $41.73 indicates a strong position just below the 60D high of $41.81. The RSI of 61.43 suggests bullish momentum, but it is approaching overbought territory, which may limit upside potential. The MA30 at $37.79 and MA50 at $35.32 indicate a positive trend, supporting a bullish bias. Given the current market context, a suggested entry point could be around $41.50, slightly below the last close to confirm buying interest. A stop loss can be placed at $40.00 to limit potential losses. For targets, consider a first target at $42.50, just above the recent high, and a second target at $43.50, allowing for further upside if momentum continues. Overall, the trade plan is to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
2TrustHim
2TrustHim Nov. 11 at 3:09 PM
0 · Reply
d_risk
d_risk Nov. 5 at 9:41 PM
$BRKR - Bruker Corporation Common Stock - 10Q - Updated Risk Factors BRKR flags new risks from recent U.S. tariffs materially impacting business and foreign currency-denominated debt exposing operations and cash flow to FX volatility, potentially restricting investments. #ScientificInstruments #CurrencyVolatility #InvestmentRestrictions #ForeignExchangeRisk #TariffImpact 🟢 Added 🟠 Removed https://d-risk.ai/BRKR/10-Q/2025-11-05
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 3:34 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 3:22 PM
Wells Fargo updates rating for Bruker ( $BRKR ) to Overweight, target set at 50 → 48.
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 6:39 PM
TD Cowen updates rating for Bruker ( $BRKR ) to Hold, target set at 40 → 42.
0 · Reply
Latest News on BRKR
Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:46 PM EST - 11 days ago

Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript


Bruker Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 7:00 AM EST - 11 days ago

Bruker Reports Third Quarter 2025 Financial Results


Bruker Announces Quarterly Dividend

Aug 12, 2025, 7:00 AM EDT - 3 months ago

Bruker Announces Quarterly Dividend


Bruker Stock: Caution Warranted Despite Bullish Analyst Calls

Aug 5, 2025, 7:12 AM EDT - 3 months ago

Bruker Stock: Caution Warranted Despite Bullish Analyst Calls


Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 12:45 PM EDT - 3 months ago

Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript


Bruker Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 7:00 AM EDT - 3 months ago

Bruker Reports Second Quarter 2025 Financial Results


Bruker Launches Revolutionary timsOmniTM Mass Spectrometer

May 30, 2025, 8:00 AM EDT - 6 months ago

Bruker Launches Revolutionary timsOmniTM Mass Spectrometer


Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript

May 7, 2025, 1:12 PM EDT - 6 months ago

Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript


Bruker Reports First Quarter 2025 Financial Results

May 7, 2025, 7:00 AM EDT - 6 months ago

Bruker Reports First Quarter 2025 Financial Results


Bruker Introduces nVista 2P Miniature Microscope

Apr 17, 2025, 9:00 AM EDT - 7 months ago

Bruker Introduces nVista 2P Miniature Microscope


Why Is Life Science Focused Bruker Stock Trading Higher On Friday?

Apr 11, 2025, 10:17 AM EDT - 7 months ago

Why Is Life Science Focused Bruker Stock Trading Higher On Friday?


Bruker Announces First Quarter 2025 Preliminary Revenue

Apr 11, 2025, 8:00 AM EDT - 7 months ago

Bruker Announces First Quarter 2025 Preliminary Revenue


Bruker Appoints Laura Francis to its Board of Directors

Feb 21, 2025, 8:00 AM EST - 9 months ago

Bruker Appoints Laura Francis to its Board of Directors

SIBN


Bruker Corporation to Present at Upcoming Investor Conferences

Feb 20, 2025, 4:01 PM EST - 9 months ago

Bruker Corporation to Present at Upcoming Investor Conferences


Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 3:22 PM EST - 9 months ago

Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:50 AM
$BRKR: The last close at $41.62 indicates a strong position above the 30-day moving average (MA30) of $38.43 and the 50-day moving average (MA50) of $36.04, suggesting bullish momentum. The RSI at 62.46 indicates that the stock is nearing overbought territory, but not excessively so, allowing for potential further upside. The recent high of $43.37 provides a key resistance level, while the low of $28.53 establishes a solid support base. Directional bias is bullish due to the price being above both MAs and the recent high. Suggested entry is at $41.50, with a stop-loss at $40.00 to manage risk. Target 1 is set at $43.00, just below the 60D high, and Target 2 at $44.00, allowing for potential breakout gains. Monitor RSI for signs of reversal as targets approach. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:23 AM
$BRKR: The last close at $41.79 indicates a strong position above the 30-day MA of $38.28 and the 50-day MA of $35.83, suggesting bullish momentum. The RSI at 61.48 indicates the stock is approaching overbought territory but is not yet there, allowing for potential upward movement. The recent 60-day high of $43.37 provides a clear resistance level, while the low of $28.53 offers significant support. Directional bias is bullish due to the stock trading above key moving averages and the RSI indicating strength. Suggested entry: $41.80 (slightly above the last close to confirm momentum). Stop: $40.00 (below recent support levels). Targets: $43.00 (near the 60D high) and $44.00 (psychological resistance). Monitor for any changes in market sentiment or volatility that could impact these levels. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:30 AM
$BRKR: The last close at $41.73 indicates a strong position just below the 60D high of $41.81. The RSI of 61.43 suggests bullish momentum, but it is approaching overbought territory, which may limit upside potential. The MA30 at $37.79 and MA50 at $35.32 indicate a positive trend, supporting a bullish bias. Given the current market context, a suggested entry point could be around $41.50, slightly below the last close to confirm buying interest. A stop loss can be placed at $40.00 to limit potential losses. For targets, consider a first target at $42.50, just above the recent high, and a second target at $43.50, allowing for further upside if momentum continues. Overall, the trade plan is to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
Professler
Professler Nov. 12 at 7:50 PM
$BRKR The buys keep coming in here. Up 40% in 3 months. No reason this shouldn't be 60s soon.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:06 AM
$BRKR: The last close at $41.73 indicates a strong position just below the 60D high of $41.81. The RSI of 61.43 suggests bullish momentum, but it is approaching overbought territory, which may limit upside potential. The MA30 at $37.79 and MA50 at $35.32 indicate a positive trend, supporting a bullish bias. Given the current market context, a suggested entry point could be around $41.50, slightly below the last close to confirm buying interest. A stop loss can be placed at $40.00 to limit potential losses. For targets, consider a first target at $42.50, just above the recent high, and a second target at $43.50, allowing for further upside if momentum continues. Overall, the trade plan is to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
2TrustHim
2TrustHim Nov. 11 at 3:09 PM
0 · Reply
d_risk
d_risk Nov. 5 at 9:41 PM
$BRKR - Bruker Corporation Common Stock - 10Q - Updated Risk Factors BRKR flags new risks from recent U.S. tariffs materially impacting business and foreign currency-denominated debt exposing operations and cash flow to FX volatility, potentially restricting investments. #ScientificInstruments #CurrencyVolatility #InvestmentRestrictions #ForeignExchangeRisk #TariffImpact 🟢 Added 🟠 Removed https://d-risk.ai/BRKR/10-Q/2025-11-05
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 3:34 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 3:22 PM
Wells Fargo updates rating for Bruker ( $BRKR ) to Overweight, target set at 50 → 48.
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 6:39 PM
TD Cowen updates rating for Bruker ( $BRKR ) to Hold, target set at 40 → 42.
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 3:36 PM
UBS updates rating for Bruker ( $BRKR ) to Neutral, target set at 40 → 43.
0 · Reply
erevnon
erevnon Nov. 4 at 2:59 PM
Barclays maintains Bruker $BRKR at Overweight and raises the price target from $40 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Nov. 4 at 2:07 PM
Barclays updates rating for Bruker ( $BRKR ) to Overweight, target set at 40 → 45.
0 · Reply
DonCorleone77
DonCorleone77 Nov. 3 at 12:08 PM
$BRKR Bruker reports Q3 EPS 45c, consensus 33c -- Q3 revenue $860.5M, consensus $847.04M. -- Cuts FY25 EPS view to $1.85-$1.90 from $1.95-$2.05, consensus $1.94 -- Cuts FY25 revenue view to $3.41B-$3.44B from $3.43B-$3.5B, consensus $3.44B.
1 · Reply
Halo202
Halo202 Nov. 2 at 9:41 PM
$BRKR $42+ by Friday
0 · Reply
ChessGM
ChessGM Nov. 1 at 11:59 PM
$BRKR "Heads up alert! Only two days until Upcoming earnings on Monday, 11/3/2025 for $BRKR Bullish (7.5) Bruker Corporation (NASDAQ: BRKR) has recently demonstrated a positive momentum in its stock performance, characterized by a nearly 25% rally over the past month, which is a significant recovery from earlier declines. This surge can be attributed to a combination of optimism surrounding upcoming earnings, increased insider buying, and substantial new orders for advanced Nuclear Magnetic Resonance (NMR) instruments, valued at approximately $10 million, from prestigious U.S. research institutions. The company’s P/E ratio stands at around 20, which is competitive within the scientific instruments sector, suggesting that the stock is reasonably valued compared to its peers. Additionally, Bruker has shown an EPS growth rate of 5% over the past year, and revenue forecasts are expected to reflect a modest increase driven by strong demand for its innovative products. When compared to industry averages, Bruker's performance metrics indicate a solid position within the market, despite a challenging year. In terms of upcoming earnings reports, Bruker is scheduled to announce its third-quarter results on November 3, 2025. Analysts are projecting a decline in earnings, which has raised concerns about the company’s ability to meet market expectations. Historically, Bruker has faced volatility in its earnings performance, and the consensus estimate suggests that while the company might not exceed expectations, the recent order inflow could provide a buffer against significant declines. Analysts are closely monitoring these developments, as any positive surprise could lead to a further rally in the stock price, while a miss could dampen investor sentiment. Overall, the scientific instruments sector, to which Bruker belongs, has shown resilience amid broader market fluctuations, driven by ongoing demand for research and healthcare solutions. Companies within this sector have generally reported stable revenue growth, and Bruker’s recent performance aligns with these trends, positioning it favorably for future growth opportunities. - Funds were net buyers of $BRKR during the previous reporting quarter. - Funds with large holdings in $BRKR include: - Orbis Holdings LTD, MV: $193MM. New position. Fund Rank: 72% www.orbis.com - Pembroke Management LLC, MV: $17MM. Fund Rank: 56% www.private.pml.ca - Alyeska Investments, MV: $13MM. Fund Rank: 79% - Adage Capital P, MV: $12MM. New position. Fund Rank: 89% www.adagecapital.com - Point72 Asset Management LP, MV: $11MM. Fund Rank: 91% www.point72.com - Last 10 days performance: 0% - Last 30 days performance: 12% - Last 90 days performance: 3% Some of the latest news articles: - Title: Why Bruker (BRKR) Stock Is Trading Up Today Publication Date: 10/31/2025 7:20:42 PM, Source: yahoo URL: https://finance.yahoo.com/news/why-bruker-brkr-stock-trading-192042799.html?.tsrc=rss - Title: Bruker (BRKR) Stock’s 25% Rally: Is There More Value for Investors? Publication Date: 10/29/2025 5:09:44 AM, Source: yahoo URL: https://finance.yahoo.com/news/bruker-brkr-stock-25-rally-050944845.html?.tsrc=rss - Title: Earnings Preview: Bruker (BRKR) Q3 Earnings Expected to Decline Publication Date: 10/27/2025 2:00:09 PM, Source: yahoo URL: https://finance.yahoo.com/news/earnings-preview-bruker-brkr-q3-140009888.html?.tsrc=rss - Title: 1 Profitable Stock with Exciting Potential and 2 We Ignore Publication Date: 10/24/2025 4:41:13 AM, Source: yahoo URL: https://finance.yahoo.com/news/1-profitable-stock-exciting-potential-044113667.html?.tsrc=rss Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 27 at 9:37 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 26 at 11:35 PM
$BC $BEAM $BRCB $BRKR $BROS 🔥 Cycle Trading Signal plugged into AI 🔥 lists
0 · Reply
victorgn
victorgn Oct. 21 at 7:42 PM
$BRKR run up
0 · Reply
victorgn
victorgn Oct. 21 at 6:34 PM
$BRKR back to $40
0 · Reply
OptionRunners
OptionRunners Oct. 21 at 3:05 PM
$BRKR Buyer of the March 20th 2026 $30 calls (ITM) 2,000 times for $12.20
0 · Reply
Ingo420
Ingo420 Oct. 16 at 8:30 PM
$BRKR how the hell did this hold up so well today? bright green in a sea of red.
0 · Reply